At close: March 14 at 3:59:58 PM EDT ...

Synairgen, a Southampton-based respiratory company developing antiviral protein interferon beta, has revealed plans to cancel its AIM listing. The listed firm intends to delist its ordinary shares and ...

Drug value assessments generally fail to account for the complexities of health care systems and thus can misinform price negotiations and lead to overly restrictive access policies. Studies have ...

Hunan Provincial Key Laboratory of Cytochemistry, School of Chemistry and Pharmaceutical Engineering, Changsha University of Science and Technology, Changsha 410114, PR China Hunan Provincial Key ...